Fig. 2
From: SP, CGRP changes in pyridoxine induced neuropathic dogs with nerve growth factor gene therapy
Body weight changes significantly only in the vehicle-treated group (p < 0.01) after pyridoxine treatment. This result evidences that NGF gene therapy in this study alleviated neuropathic pain, protecting the DRG from the neuropathic pain normally produced by pyridoxine (n = 4 per group)